Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
13 hedge funds and large institutions have $37.8M invested in Aratana Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Wellington Management Group
Boston,
Massachusetts
| $7.93M | +$8.3M | +1,049,390 | New |
|
2
Adage Capital Partners
Boston,
Massachusetts
| $7.56M | +$7.91M | +1,000,000 | New |
|
|
AWMDMG
3
Austin W. Marxe & David M. Greenhouse
New York
| $5.79M | +$6.06M | +766,440 | New |
|
4
JP Morgan Chase
New York
| $5.49M | +$5.74M | +726,200 | New |
|
5
Jennison Associates
New York
| $3.21M | +$3.36M | +425,000 | New |
|
6
Principal Financial Group
Des Moines,
Iowa
| $2.65M | +$2.77M | +350,000 | New |
|
7
D.E. Shaw & Co
New York
| $1.8M | +$1.88M | +237,752 | New |
|
|
MAM
8
MPM Asset Management
Boston,
Massachusetts
| $1.36M | +$1.43M | +180,505 | New |
|
|
HHC
9
Hutchin Hill Capital
New York
| $1.32M | +$1.38M | +175,000 | New |
|
|
KIA
10
Kopp Investment Advisors
Bloomington,
Minnesota
| $403K | +$422K | +53,295 | New |
|
|
RSCM
11
Rail-Splitter Capital Management
Chicago,
Illinois
| $189K | +$198K | +25,000 | New |
|
12
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $44K | +$46.7K | +5,900 | New |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| – | +$79 | +10 | New |
|
PETX Hedge Fund Activity: Q2 2013 in Review
13 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q2 2013, worth a combined $37.8M.
Buyers outnumbered sellers: 13 funds opened new PETX positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.
- 13 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $37.8M of Aratana Therapeutics, Inc. stock for Q2 2013.
- 13 funds opened new Aratana Therapeutics, Inc. positions in Q2 2013 and 0 closed out, a net change of +13 holders.
Based on aggregated 13F filings for Q2 2013.